Abstract:Orphanin FQ (nociceptin, OFQ), a hepatdecapeptide peptide, has been designated as an endogenous ligand at the orphan receptor ORL1, which lacks affinity for opioid receptor ligands. OFQ-like immunoreactivity has been localized in spinal cord areas that are involved in the processing of nociceptive signals. In this study, the effects of spinally administered OFQ on thermal and mechanical nociceptive stimuli were investigated following intrathecal (i.t.) injection in unanesthetized rats bearing chronic indwelling catheters in the subarachnoid space. Intrathecal OFQ produced two distinct acute actions: an opioid-like antinociceptive effect, and antagonism of morphine-induced antinociception. Chronic administration produces tolerance. Acute actions were as follows. First, injection of OFQ alone in the dose range 10-100 nmol produced sustained antinociceptive effects in the tail-flick (baseline latency 1.5-2 s) and paw-pressure tests. These effects peaked at 45-60 min post-injection, were fully reversible, and were observed in absence of discernable motor impairments. Intrathecal naloxone (5 nmol) significantly attenuated the antinociceptive effects of OFQ (50 nmol i.t.) in tail-flick and paw-pressure tests. A 24-h pretreatment with the irreversible opioid receptor antagonist, beta-flunatrexamine (2 nmol i.t.), also attenuated the antinociceptive effects of OFQ (50, 100 nmol i.t.) and of morphine (7.5 nmol i.t.) in both tests. Low doses (1, 5 nmol) of OFQ, which failed to produce antinociception in the tail-flick test involving a baseline latency of 1.5-2 s, produced a strong antinociceptive response when the baseline latency was increased to 5-6 s. Second, intrathecal OFQ, at doses (0.5, 1.0, and 5.0 nmol) that had no antinociceptive activity in the tail-flick (baseline latency 1.5-2 s) and paw-pressure tests, attenuated the antinociceptive effect of morphine (7.5 nmol i.t.) in these tests. However, a threshold OFQ dose (10 nmol) significantly extended the duration of antinociception induced by morphine (7.5 nmol i.t.) or deltorphin (20 nmol i.t.). Chronic actions were as follows. In rats that were rendered tolerant to spinal morphine, by a continuous intrathecal infusion (7.5 nmol/h) of the agonist for 5 days, the OFQ dose-response curves for its antinociceptive effect in the tail-flick and paw-pressure tests were significantly shifted to the right. In separate experiments, repeated intrathecal injection of OFQ (50 nmol) or morphine (7.5 nmol) produced a significant decline in their antinociceptive effects. Thus, intrathecally administered OFQ produces both development of tolerance to its antinociceptive actions and cross-tolerance to the action of morphine.

Effect of Nocistatin in Pain Modulation

Nocistatin Reverses the Effect of Orphanin Fq/Nociceptin in Antagonizing Morphine Analgesia

Effect of Intrathecal Nocistatin on Nociceptin/orphanin FQ Analgesia in Chronic Constriction Injury Rat

Effects of Nociceptin (13–17) in Pain Modulation at Supraspinal Level in Mice

Reversal by Nocistatin of the Effect of Nociceptin in Antagonizing Morphine Analgesia in Mice

Effects of Nocistatin and Nocistatin (10-17) on Nociceptin in Antagonizing Endomorphin-1 and Endomorphin-2 Analgesia in Mice

Nocistatin, a Peptide Reversing Acute and Chronic Morphine Tolerance

The Anti-Nociception Effect of Dezocine in a Rat Neuropathic Pain Model

Orphanin Fq Potentiates Formalin-Induced Pain Behavior and Antagonizes Morphine Analgesia in Rats

Effect of intracerebroventricular or intrathecal injection of orphanin FQ on pain and acupuncture analgesia in rats

Nociceptin/orphanin FQ into the rat periaqueductal gray decreases the withdrawal latency to heat and loading, an effect reversed by (Nphe1)nociceptin(1–13)NH2

Involvement of endogenous opioid systems in nociceptin-induced spinal antinociception in rats.

Antinociceptive and morphine modulatory actions of spinal orphanin FQ

Antagonistic Effect of Orphanin FQ on Opioid Analgesia in Rat

Functional Studies Using Antibodies Against Orphanin FQ/nociceptin

Blockade Effects of (Nphe1)nociceptin(1–13)-Nh2 on Anti-Nociception Induced by Intrathecal Administration of Nociceptin in Rats

Antiallodynic Effects of Systemic and Intrathecal Morphine in the Spared Nerve Injury Model of Neuropathic Pain in Rats

Effect of Intrathecal or Intracerebroventricular Administrition of OFQ on Pain Threshold and Acpuncture Analgesia in Rats

Nocistatin potentiates electroacupuncture antinociceptive effects and reverses chronic tolerance to electroacupuncture in mice.

Effects of Intrathecally Administerd NaV1.8 Antisense Oligonucleotide on the Expression of Sodium Channel Mrna in Dorsal Root Ganglion

Effect of Intrathecal Sufentanil and Protein Kinase C Inhibitor on Pain Threshold and the Expression of NMDA Receptor/cgrp in Spinal Dorsal Horn in Rats with Neuropathic Pain